Patents by Inventor Nicholas James GRIFFITHS-HAYNES

Nicholas James GRIFFITHS-HAYNES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl)pyrazole-4-carboxamide as iallikrein inhibitors

Patent number: 11230537

Abstract: The invention provides new polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereof, pharmaceutical compositions containing them and their use as kallikrein inhibitors in therapy.

Type: Grant

Filed: June 1, 2017

Date of Patent: January 25, 2022

Assignee: KalVista Pharmaceuticals Limited

Inventors: Haydn Beaton, David Malcolm Crowe, Hannah Joy Edwards, Nicholas James Griffiths-Haynes
POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1 -({4-[2-OXOPYRIDIN-1-YL)METHYL]PHENYL} METHYL)PYRAZOLE-4-CARBOXAMIDE AS IALLIKREIN INHIBITORS

Publication number: 20200317633

Abstract: The invention provides new polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereof, pharmaceutical compositions containing them and their use as kallikrein inhibitors in therapy

Type: Application

Filed: June 1, 2017

Publication date: October 8, 2020

Inventors: Haydn BEATON, David Malcolm CROWE, Hannah Joy EDWARDS, Nicholas James GRIFFITHS-HAYNES

Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl)pyrazole-4-carboxamide as iallikrein inhibitors

POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1 -({4-[2-OXOPYRIDIN-1-YL)METHYL]PHENYL} METHYL)PYRAZOLE-4-CARBOXAMIDE AS IALLIKREIN INHIBITORS